Title:
PAN-KRAS INHIBITOR COMPOUND
Document Type and Number:
WIPO Patent Application WO/2024/060966
Kind Code:
A1
Abstract:
The present invention relates to a pan-KRAS inhibitor compound represented by formula (I), a pharmaceutical composition comprising the compound, and use of the compound of formula (I) in preventing and/or treating cancers, tumors, inflammatory diseases, autoimmune diseases, or immune-mediated diseases.
Inventors:
CHEN YUFENG (CN)
LV MENG (CN)
LIU CANFENG (CN)
CHENG WANLI (CN)
LI FEIFAN (CN)
YANG HAN (CN)
CHEN KAIXUAN (CN)
LIU SHUAISHUAI (CN)
HE NANHAI (CN)
LV MENG (CN)
LIU CANFENG (CN)
CHENG WANLI (CN)
LI FEIFAN (CN)
YANG HAN (CN)
CHEN KAIXUAN (CN)
LIU SHUAISHUAI (CN)
HE NANHAI (CN)
Application Number:
PCT/CN2023/116437
Publication Date:
March 28, 2024
Filing Date:
September 01, 2023
Export Citation:
Assignee:
ADLAI NORTYE BIOPHARMA CO LTD (CN)
International Classes:
C07D471/22; A61K31/429; A61K31/5025; A61P35/00; C07D487/12; C07D513/22; C07D519/00
Domestic Patent References:
| WO2022212894A1 | 2022-10-06 | |||
| WO2023015559A1 | 2023-02-16 | |||
| WO2022060836A1 | 2022-03-24 | |||
| WO2021091956A1 | 2021-05-14 | |||
| WO2021091967A1 | 2021-05-14 | |||
| WO2022060583A1 | 2022-03-24 | |||
| WO2021091982A1 | 2021-05-14 |
Foreign References:
| CN113498342A | 2021-10-12 |
Attorney, Agent or Firm:
FONDEE IP LAW LLC (CN)
Download PDF: